Compare LNTH & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LNTH | BIRK |
|---|---|---|
| Founded | 1956 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 5.7B |
| IPO Year | 2014 | 2023 |
| Metric | LNTH | BIRK |
|---|---|---|
| Price | $100.93 | $34.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 14 |
| Target Price | ★ $87.00 | $61.43 |
| AVG Volume (30 Days) | 1.6M | ★ 3.0M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.91 | N/A |
| Revenue | ★ $343,374,000.00 | N/A |
| Revenue This Year | N/A | $13.71 |
| Revenue Next Year | $14.19 | $14.30 |
| P/E Ratio | $34.65 | ★ $17.48 |
| Revenue Growth | ★ 3.62 | N/A |
| 52 Week Low | $49.67 | $31.33 |
| 52 Week High | $111.86 | $51.37 |
| Indicator | LNTH | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 46.25 | 37.14 |
| Support Level | $100.51 | $33.06 |
| Resistance Level | $102.66 | $42.91 |
| Average True Range (ATR) | 0.53 | 1.30 |
| MACD | 0.15 | -0.03 |
| Stochastic Oscillator | 50.86 | 5.72 |
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.